Cargando…

Perspective on the relationship between microbiota dysbiosis and neuroinflammation: probiotics as a treatment option

Detalles Bibliográficos
Autores principales:	Ng, Chiao W., Shah, Zahoor A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848620/ https://www.ncbi.nlm.nih.gov/pubmed/35142679 http://dx.doi.org/10.4103/1673-5374.335150

Ejemplares similares

Perspective: Leveraging the Gut Microbiota to Predict Personalized Responses to Dietary, Prebiotic, and Probiotic Interventions
por: Gibbons, Sean M, et al.
Publicado: (2022)

Emerging role of gut microbiota dysbiosis in neuroinflammation and neurodegeneration
por: Solanki, Riddhi, et al.
Publicado: (2023)

Dysbiosis and Its Discontents
por: Hooks, Katarzyna B., et al.
Publicado: (2017)

Gut Microbiota Dysbiosis Induced by Intracerebral Hemorrhage Aggravates Neuroinflammation in Mice
por: Yu, Xiaobo, et al.
Publicado: (2021)

Critical need for pharmacologic treatment options in NAFLD: A pediatric perspective
por: Friesen, Chance S., et al.
Publicado: (2021)

The Dysbiosis and Inter-Kingdom Synergy Model in Oropharyngeal Candidiasis, a New Perspective in Pathogenesis
por: Bertolini, Martinna, et al.
Publicado: (2019)

Probiotics Dietary Supplementation for Modulating Endocrine and Fertility Microbiota Dysbiosis
por: López-Moreno, Ana, et al.
Publicado: (2020)

The influence of gut microbiota alteration on age-related neuroinflammation and cognitive decline
por: Alsegiani, Amsha S., et al.
Publicado: (2022)

Gut Microbiota Dysbiosis: Triggers, Consequences, Diagnostic and Therapeutic Options
por: Hrncir, Tomas
Publicado: (2022)

Neuroinflammation and glial activation in the central nervous system: a metabolic perspective
por: Virtuoso, Assunta, et al.
Publicado: (2022)

Probiotics and Clostridium Difficile: A Review of Dysbiosis and the Rehabilitation of Gut Microbiota
por: Kalakuntla, Ashish S, et al.
Publicado: (2019)

The potential application of probiotics and prebiotics for the prevention and treatment of COVID-19
por: Olaimat, Amin N., et al.
Publicado: (2020)

Early life stress-induced neuroinflammation and neurological disorders: a novel perspective for research
por: Catale, Clarissa, et al.
Publicado: (2022)

Surgical Options for Optic Disc Pit Maculopathy: Perspectives and Controversies
por: Pastor-Idoate, Salvador, et al.
Publicado: (2020)

Neuroinflammation and COVID-19
por: Vanderheiden, Abigail, et al.
Publicado: (2022)

Influence of Different Probiotic Lactic Acid Bacteria on Microbiota and Metabolism of Rats with Dysbiosis
por: ERMOLENKO, Elena, et al.
Publicado: (2013)

Bacteriocin-Producing Probiotic Lactic Acid Bacteria in Controlling Dysbiosis of the Gut Microbiota
por: Anjana,, et al.
Publicado: (2022)

MRSA and Skin Infections in Psoriatic Patients: Therapeutic Options and New Perspectives
por: Rizzetto, Giulio, et al.
Publicado: (2022)

Relationship between gut microbiota dysbiosis and immune indicator in children with sepsis
por: Lin, Xia, et al.
Publicado: (2023)

Perspective: Fundamental Limitations of the Randomized Controlled Trial Method in Nutritional Research: The Example of Probiotics
por: Zeilstra, Dennis, et al.
Publicado: (2018)

Western lifestyle as a driver of dysbiosis in colorectal cancer
por: Foegeding, Nora J., et al.
Publicado: (2021)

Challenges & options in dengue prevention & control: A perspective from the 2015 outbreak
por: Jain, Siddharth, et al.
Publicado: (2017)

Perspective: Is therapeutic plasma exchange a viable option for treating Alzheimer's disease?
por: Imbimbo, Bruno P., et al.
Publicado: (2020)

Nisin a probiotic bacteriocin mitigates brain microbiome dysbiosis and Alzheimer’s disease-like neuroinflammation triggered by periodontal disease
por: Zhao, Chuanjiang, et al.
Publicado: (2023)

Parkinson’s Disease: The Emerging Role of Gut Dysbiosis, Antibiotics, Probiotics, and Fecal Microbiota Transplantation
por: Dutta, Sudhir K, et al.
Publicado: (2019)

Atopobiosis and Dysbiosis in Ocular Diseases: Is Fecal Microbiota Transplant and Probiotics a Promising Solution?
por: Gunardi, Triana Hardianti, et al.
Publicado: (2021)

Dysbiosis and Prematurity: Is There a Role for Probiotics?
por: Baldassarre, Maria Elisabetta, et al.
Publicado: (2019)

Dysbiosis, Probiotics, and Prebiotics: In Diseases and Health
por: Appanna, Vasu D.
Publicado: (2018)

Administration of pre/probiotics with conventional drug treatment in Alzheimer’s disease
por: Hort, Jakub, et al.
Publicado: (2019)

Iron, the endolysosomal system and neuroinflammation: a matter of balance
por: Bórquez, Daniel A., et al.
Publicado: (2021)

Neurodegeneration and neuroinflammation: two processes, one target
por: Carriba, Paulina, et al.
Publicado: (2015)

Microglial exosomes in retinal neuroinflammation: focus in glaucoma
por: Aires, Inês Dinis, et al.
Publicado: (2021)

Effects of Ketogenic Diet on Neuroinflammation in Neurodegenerative Diseases
por: Jiang, Ziying, et al.
Publicado: (2022)

Advanced brain organoids for neuroinflammation disease modeling
por: Sabate-Soler, Sonia, et al.
Publicado: (2023)

Repair and regeneration properties of Ginkgo biloba after ischemic brain injury
por: Raghavan, Aparna, et al.
Publicado: (2014)

Withania somnifera: a pre-clinical study on neuroregenerative therapy for stroke
por: Raghavan, Aparna, et al.
Publicado: (2015)

Interaction between Gut Microbiota and Celiac Disease: From Pathogenesis to Treatment
por: Rossi, Roberta Elisa, et al.
Publicado: (2023)

Exploring Next Generation Probiotics for Metabolic and Microbiota Dysbiosis Linked to Xenobiotic Exposure: Holistic Approach
por: Torres-Sánchez, Alfonso, et al.
Publicado: (2022)

Effects of Unconventional Work and Shift Work on the Human Gut Microbiota and the Potential of Probiotics to Restore Dysbiosis
por: Lopez-Santamarina, Aroa, et al.
Publicado: (2023)

The role of cofilin in age-related neuroinflammation
por: Alsegiani, Amsha S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p5lf6fg7ao08t19q4h66s7omol